vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and Turning Point Brands, Inc. (TPB). Click either name above to swap in a different company.

Turning Point Brands, Inc. is the larger business by last-quarter revenue ($121.0M vs $90.3M, roughly 1.3× Evolus, Inc.). Turning Point Brands, Inc. runs the higher net margin — 6.8% vs 0.1%, a 6.6% gap on every dollar of revenue. On growth, Turning Point Brands, Inc. posted the faster year-over-year revenue change (29.2% vs 14.4%). Turning Point Brands, Inc. produced more free cash flow last quarter ($21.5M vs $11.3M). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs 20.7%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

Turning Point Australia (TPAUS) is a conservative lobby group based in Australia, affiliated with Turning Point USA but independent of it. Founded by Joel Jammal and first registered in 2023, the group has become active in trying to influence the outcome of the 2026 South Australian state election in March 2026.

EOLS vs TPB — Head-to-Head

Bigger by revenue
TPB
TPB
1.3× larger
TPB
$121.0M
$90.3M
EOLS
Growing faster (revenue YoY)
TPB
TPB
+14.8% gap
TPB
29.2%
14.4%
EOLS
Higher net margin
TPB
TPB
6.6% more per $
TPB
6.8%
0.1%
EOLS
More free cash flow
TPB
TPB
$10.2M more FCF
TPB
$21.5M
$11.3M
EOLS
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
23.4%
20.7%
TPB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EOLS
EOLS
TPB
TPB
Revenue
$90.3M
$121.0M
Net Profit
$130.0K
$8.2M
Gross Margin
65.7%
55.9%
Operating Margin
4.7%
16.5%
Net Margin
0.1%
6.8%
Revenue YoY
14.4%
29.2%
Net Profit YoY
101.9%
239.8%
EPS (diluted)
$0.01
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
TPB
TPB
Q4 25
$90.3M
$121.0M
Q3 25
$69.0M
$119.0M
Q2 25
$69.4M
$116.6M
Q1 25
$68.5M
$106.4M
Q4 24
$78.9M
$93.7M
Q3 24
$61.1M
$90.7M
Q2 24
$66.9M
$93.2M
Q1 24
$59.3M
$83.1M
Net Profit
EOLS
EOLS
TPB
TPB
Q4 25
$130.0K
$8.2M
Q3 25
$-15.7M
$21.1M
Q2 25
$-17.1M
$14.5M
Q1 25
$-18.9M
$14.4M
Q4 24
$-6.8M
$2.4M
Q3 24
$-19.2M
$12.4M
Q2 24
$-11.3M
$13.0M
Q1 24
$-13.1M
$12.0M
Gross Margin
EOLS
EOLS
TPB
TPB
Q4 25
65.7%
55.9%
Q3 25
66.5%
59.2%
Q2 25
65.3%
57.1%
Q1 25
68.1%
56.0%
Q4 24
66.7%
56.0%
Q3 24
68.9%
55.6%
Q2 24
70.3%
54.1%
Q1 24
68.3%
58.2%
Operating Margin
EOLS
EOLS
TPB
TPB
Q4 25
4.7%
16.5%
Q3 25
-16.7%
21.8%
Q2 25
-14.7%
22.6%
Q1 25
-22.1%
21.8%
Q4 24
-2.9%
19.1%
Q3 24
-25.3%
22.9%
Q2 24
-11.5%
24.5%
Q1 24
-15.0%
23.2%
Net Margin
EOLS
EOLS
TPB
TPB
Q4 25
0.1%
6.8%
Q3 25
-22.8%
17.7%
Q2 25
-24.7%
12.4%
Q1 25
-27.6%
13.5%
Q4 24
-8.6%
2.6%
Q3 24
-31.4%
13.6%
Q2 24
-17.0%
14.0%
Q1 24
-22.1%
14.5%
EPS (diluted)
EOLS
EOLS
TPB
TPB
Q4 25
$0.01
$0.40
Q3 25
$-0.24
$1.13
Q2 25
$-0.27
$0.79
Q1 25
$-0.30
$0.79
Q4 24
$-0.11
$0.15
Q3 24
$-0.30
$0.68
Q2 24
$-0.18
$0.68
Q1 24
$-0.22
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
TPB
TPB
Cash + ST InvestmentsLiquidity on hand
$53.8M
$222.8M
Total DebtLower is stronger
$146.1M
Stockholders' EquityBook value
$-23.1M
$372.0M
Total Assets
$225.9M
$763.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
TPB
TPB
Q4 25
$53.8M
$222.8M
Q3 25
$43.5M
$201.2M
Q2 25
$61.7M
$109.9M
Q1 25
$67.9M
$99.6M
Q4 24
$87.0M
$48.9M
Q3 24
$85.0M
$33.6M
Q2 24
$93.7M
$142.2M
Q1 24
$97.0M
$130.9M
Total Debt
EOLS
EOLS
TPB
TPB
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Q1 24
$120.6M
Stockholders' Equity
EOLS
EOLS
TPB
TPB
Q4 25
$-23.1M
$372.0M
Q3 25
$-28.8M
$358.2M
Q2 25
$-18.7M
$224.8M
Q1 25
$-6.6M
$203.4M
Q4 24
$5.5M
$190.4M
Q3 24
$5.9M
$185.7M
Q2 24
$19.3M
$172.8M
Q1 24
$18.4M
$160.0M
Total Assets
EOLS
EOLS
TPB
TPB
Q4 25
$225.9M
$763.8M
Q3 25
$219.0M
$742.8M
Q2 25
$228.8M
$595.8M
Q1 25
$213.4M
$564.6M
Q4 24
$232.6M
$493.4M
Q3 24
$229.6M
$488.0M
Q2 24
$233.8M
$591.6M
Q1 24
$226.2M
$586.3M
Debt / Equity
EOLS
EOLS
TPB
TPB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×
Q1 24
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
TPB
TPB
Operating Cash FlowLast quarter
$12.8M
$24.9M
Free Cash FlowOCF − Capex
$11.3M
$21.5M
FCF MarginFCF / Revenue
12.6%
17.8%
Capex IntensityCapex / Revenue
1.6%
2.8%
Cash ConversionOCF / Net Profit
98.67×
3.03×
TTM Free Cash FlowTrailing 4 quarters
$-45.7M
$43.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
TPB
TPB
Q4 25
$12.8M
$24.9M
Q3 25
$-14.7M
$3.3M
Q2 25
$-24.8M
$11.8M
Q1 25
$-15.6M
$17.4M
Q4 24
$4.8M
$17.7M
Q3 24
$-5.7M
$13.2M
Q2 24
$-6.5M
$13.4M
Q1 24
$-10.6M
$22.6M
Free Cash Flow
EOLS
EOLS
TPB
TPB
Q4 25
$11.3M
$21.5M
Q3 25
$-15.6M
$-721.0K
Q2 25
$-25.5M
$7.8M
Q1 25
$-16.0M
$15.2M
Q4 24
$4.4M
$16.6M
Q3 24
$-6.0M
$12.6M
Q2 24
$-6.9M
$10.9M
Q1 24
$-10.9M
$22.3M
FCF Margin
EOLS
EOLS
TPB
TPB
Q4 25
12.6%
17.8%
Q3 25
-22.7%
-0.6%
Q2 25
-36.7%
6.7%
Q1 25
-23.3%
14.3%
Q4 24
5.5%
17.8%
Q3 24
-9.9%
13.9%
Q2 24
-10.4%
11.7%
Q1 24
-18.3%
26.8%
Capex Intensity
EOLS
EOLS
TPB
TPB
Q4 25
1.6%
2.8%
Q3 25
1.4%
3.4%
Q2 25
1.0%
3.4%
Q1 25
0.5%
2.1%
Q4 24
0.6%
1.2%
Q3 24
0.5%
0.7%
Q2 24
0.7%
2.7%
Q1 24
0.4%
0.4%
Cash Conversion
EOLS
EOLS
TPB
TPB
Q4 25
98.67×
3.03×
Q3 25
0.16×
Q2 25
0.82×
Q1 25
1.21×
Q4 24
7.34×
Q3 24
1.07×
Q2 24
1.03×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Segment breakdown not available.

TPB
TPB

US$111.5M92%
Non Us$9.6M8%

Related Comparisons